Literature DB >> 22030351

Expression of PTRF in PC-3 Cells modulates cholesterol dynamics and the actin cytoskeleton impacting secretion pathways.

Kerry L Inder1, Yu Zi Zheng, Melissa J Davis, Hyeongsun Moon, Dorothy Loo, Hien Nguyen, Judith A Clements, Robert G Parton, Leonard J Foster, Michelle M Hill.   

Abstract

Expression of caveolin-1 is up-regulated in prostate cancer metastasis and is associated with aggressive recurrence of the disease. Intriguingly, caveolin-1 is also secreted from prostate cancer cell lines and has been identified in secreted prostasomes. Caveolin-1 is the major structural component of the plasma membrane invaginations called caveolae. Co-expression of the coat protein Polymerase I and transcript release factor (PTRF) is required for caveolae formation. We recently found that expression of caveolin-1 in the aggressive prostate cancer cell line PC-3 is not accompanied by PTRF, leading to noncaveolar caveolin-1 lipid rafts. Moreover, ectopic expression of PTRF in PC-3 cells sequesters caveolin-1 into caveolae. Here we quantitatively analyzed the effect of PTRF expression on the PC-3 proteome using stable isotope labeling by amino acids in culture and subcellular proteomics. We show that PTRF reduced the secretion of a subset of proteins including secreted proteases, cytokines, and growth regulatory proteins, partly via a reduction in prostasome secretion. To determine the cellular mechanism accounting for the observed reduction in secreted proteins we analyzed total membrane and the detergent-resistant membrane fractions. Our data show that PTRF expression selectively impaired the recruitment of actin cytoskeletal proteins to the detergent-resistant membrane, which correlated with altered cholesterol distribution in PC-3 cells expressing PTRF. Consistent with this, modulating cellular cholesterol altered the actin cytoskeleton and protein secretion in PC-3 cells. Intriguingly, several proteins that function in ER to Golgi trafficking were reduced by PTRF expression. Taken together, these results suggest that the noncaveolar caveolin-1 found in prostate cancer cells generates a lipid raft microenvironment that accentuates secretion pathways, possibly at the step of ER sorting/exit. Importantly, these effects could be modulated by PTRF expression.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22030351      PMCID: PMC3277761          DOI: 10.1074/mcp.M111.012245

Source DB:  PubMed          Journal:  Mol Cell Proteomics        ISSN: 1535-9476            Impact factor:   5.911


  47 in total

1.  Identification of filamin as a novel ligand for caveolin-1: evidence for the organization of caveolin-1-associated membrane domains by the actin cytoskeleton.

Authors:  M Stahlhut; B van Deurs
Journal:  Mol Biol Cell       Date:  2000-01       Impact factor: 4.138

2.  Secreted caveolin-1 stimulates cell survival/clonal growth and contributes to metastasis in androgen-insensitive prostate cancer.

Authors:  S A Tahir; G Yang; S Ebara; T L Timme; T Satoh; L Li; A Goltsov; M Ittmann; J D Morrisett; T C Thompson
Journal:  Cancer Res       Date:  2001-05-15       Impact factor: 12.701

Review 3.  Exosomes: composition, biogenesis and function.

Authors:  Clotilde Théry; Laurence Zitvogel; Sebastian Amigorena
Journal:  Nat Rev Immunol       Date:  2002-08       Impact factor: 53.106

4.  Regulated apical secretion of zymogens in rat pancreas. Involvement of the glycosylphosphatidylinositol-anchored glycoprotein GP-2, the lectin ZG16p, and cholesterol-glycosphingolipid-enriched microdomains.

Authors:  K Schmidt; M Schrader; H F Kern; R Kleene
Journal:  J Biol Chem       Date:  2001-01-10       Impact factor: 5.157

5.  Phosphatidylinositol 4,5-bisphosphate induces actin-based movement of raft-enriched vesicles through WASP-Arp2/3.

Authors:  A L Rozelle; L M Machesky; M Yamamoto; M H Driessens; R H Insall; M G Roth; K Luby-Phelps; G Marriott; A Hall; H L Yin
Journal:  Curr Biol       Date:  2000-03-23       Impact factor: 10.834

6.  Late endosome motility depends on lipids via the small GTPase Rab7.

Authors:  Cécile Lebrand; Michela Corti; Holly Goodson; Pierre Cosson; Valeria Cavalli; Nathalie Mayran; Julien Fauré; Jean Gruenberg
Journal:  EMBO J       Date:  2002-03-15       Impact factor: 11.598

7.  Cholesterol is required for the formation of regulated and constitutive secretory vesicles from the trans-Golgi network.

Authors:  Y Wang; C Thiele; W B Huttner
Journal:  Traffic       Date:  2000-12       Impact factor: 6.215

Review 8.  Roles of lipid rafts in membrane transport.

Authors:  E Ikonen
Journal:  Curr Opin Cell Biol       Date:  2001-08       Impact factor: 8.382

9.  Lipid raft association of carboxypeptidase E is necessary for its function as a regulated secretory pathway sorting receptor.

Authors:  S Dhanvantari; Y P Loh
Journal:  J Biol Chem       Date:  2000-09-22       Impact factor: 5.157

10.  Serum interleukin 6 as a prognostic factor in patients with prostate cancer.

Authors:  J Nakashima; M Tachibana; Y Horiguchi; M Oya; T Ohigashi; H Asakura; M Murai
Journal:  Clin Cancer Res       Date:  2000-07       Impact factor: 12.531

View more
  32 in total

Review 1.  Extracellular vesicles such as prostate cancer cell fragments as a fluid biopsy for prostate cancer.

Authors:  S I Brett; Y Kim; C N Biggs; J L Chin; H S Leong
Journal:  Prostate Cancer Prostatic Dis       Date:  2015-05-12       Impact factor: 5.554

Review 2.  Bioanalysis of eukaryotic organelles.

Authors:  Chad P Satori; Michelle M Henderson; Elyse A Krautkramer; Vratislav Kostal; Mark D Distefano; Mark M Distefano; Edgar A Arriaga
Journal:  Chem Rev       Date:  2013-04-10       Impact factor: 60.622

3.  Cavin-1 and Caveolin-1 are both required to support cell proliferation, migration and anchorage-independent cell growth in rhabdomyosarcoma.

Authors:  Fiorella Faggi; Nicola Chiarelli; Marina Colombi; Stefania Mitola; Roberto Ronca; Luca Madaro; Marina Bouche; Pietro L Poliani; Marika Vezzoli; Francesca Longhena; Eugenio Monti; Barbara Salani; Davide Maggi; Charles Keller; Alessandro Fanzani
Journal:  Lab Invest       Date:  2015-03-30       Impact factor: 5.662

4.  Critical role of CAV1/caveolin-1 in cell stress responses in human breast cancer cells via modulation of lysosomal function and autophagy.

Authors:  Yin Shi; Shi-Hao Tan; Shukie Ng; Jing Zhou; Na-Di Yang; Gi-Bang Koo; Kerrie-Ann McMahon; Robert G Parton; Michelle M Hill; Miguel A Del Pozo; You-Sun Kim; Han-Ming Shen
Journal:  Autophagy       Date:  2015       Impact factor: 16.016

Review 5.  Caveolin-1, caveolae, and glioblastoma.

Authors:  Marie-Odile Parat; Gregory J Riggins
Journal:  Neuro Oncol       Date:  2012-04-16       Impact factor: 12.300

Review 6.  A new role for extracellular vesicles: how small vesicles can feed tumors' big appetite.

Authors:  Ikrame Lazar; Emily Clement; Camille Attane; Catherine Muller; Laurence Nieto
Journal:  J Lipid Res       Date:  2018-04-20       Impact factor: 5.922

7.  Proteomic analysis of microvesicles released by the human prostate cancer cell line PC-3.

Authors:  Kirsten Sandvig; Alicia Llorente
Journal:  Mol Cell Proteomics       Date:  2012-03-28       Impact factor: 5.911

8.  The cancer-associated microprotein CASIMO1 controls cell proliferation and interacts with squalene epoxidase modulating lipid droplet formation.

Authors:  Maria Polycarpou-Schwarz; Matthias Groß; Pieter Mestdagh; Johanna Schott; Stefanie E Grund; Catherina Hildenbrand; Joachim Rom; Sebastian Aulmann; Hans-Peter Sinn; Jo Vandesompele; Sven Diederichs
Journal:  Oncogene       Date:  2018-05-16       Impact factor: 9.867

Review 9.  Interaction of membrane/lipid rafts with the cytoskeleton: impact on signaling and function: membrane/lipid rafts, mediators of cytoskeletal arrangement and cell signaling.

Authors:  Brian P Head; Hemal H Patel; Paul A Insel
Journal:  Biochim Biophys Acta       Date:  2013-07-27

Review 10.  Caveola-forming proteins caveolin-1 and PTRF in prostate cancer.

Authors:  Zeyad D Nassar; Michelle M Hill; Robert G Parton; Marie-Odile Parat
Journal:  Nat Rev Urol       Date:  2013-08-13       Impact factor: 14.432

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.